AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 6.15%54.020.9%$2353.35m
JNJJohnson & Johnson -0.62%159.250.7%$1167.23m
MRKMerck & Co., Inc. -3.83%79.130.7%$1134.44m
LLYEli Lilly & Co. -0.57%260.501.1%$694.38m
BMYBristol-Myers Squibb Co. -0.53%56.511.0%$694.21m
ABBVAbbVie, Inc. -1.80%116.531.9%$669.66m
AZNAstraZeneca Plc 0.43%56.581.0%$278.35m
GSKGlaxoSmithKline Plc -1.42%41.010.2%$185.81m
NVSNovartis AG -1.44%80.730.2%$180.89m
BFRIBiofrontera, Inc. 51.34%7.900.0%$139.46m
VTRSViatris, Inc. -2.30%12.750.0%$132.99m
RGENRepligen Corp. 5.21%286.016.7%$112.80m
RPRXRoyalty Pharma Plc -0.45%41.890.1%$106.76m
DRNADicerna Pharmaceuticals, Inc. -0.03%37.990.3%$106.72m
NVONovo Nordisk A/S -0.76%108.210.1%$96.98m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.